engleski

Once unthinkable, today everyday life

According to data, in Croatia lung cancer is the second most common cancer in men, and third in women. There are two groups of lung cancers: small celland, more commonly, non-small cell lung cancer (NSCLC). In about 5% of NSCLC, impaired gene expression of anaplastic lymphoma kinase (ALK) occurs and consequently a fusion oncogene is formed. ALK-positive NSCLC is very sensitive to ALK inhibitors andalectinib represents the first line of treatment for advanced cases.

Alectinib, ALK, NSCLC

nije evidentirano